{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:06:47Z","timestamp":1790795207094,"version":"4.1.0"},"reference-count":237,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Spinal muscular atrophy (SMA) is a leading genetic cause of infant death worldwide that is characterized by loss of spinal motor neurons leading to muscle weakness and atrophy. SMA results from the loss of survival motor neuron 1 (SMN1) gene but retention of its paralog SMN2. The copy numbers of SMN1 and SMN2 are variable within the human population with SMN2 copy number inversely correlating with SMA severity. Current therapeutic options for SMA focus on increasing SMN2 expression and alternative splicing so as to increase the amount of SMN protein. Recent work has demonstrated that not all SMN2, or SMN1, genes are equivalent and there is a high degree of genomic heterogeneity with respect to the SMN genes. Because SMA is now an actionable disease with SMN2 being the primary target, it is imperative to have a comprehensive understanding of this genomic heterogeneity with respect to hybrid SMN1\u2013SMN2 genes generated by gene conversion events as well as partial deletions of the SMN genes. This review will describe this genetic heterogeneity in SMA and its impact on disease phenotype as well as therapeutic efficacy.<\/jats:p>","DOI":"10.3390\/ijms22157896","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T22:06:21Z","timestamp":1627250781000},"page":"7896","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2912-6400","authenticated-orcid":false,"given":"Matthew E. R.","family":"Butchbach","sequence":"first","affiliation":[{"name":"Center for Applied Clinical Genomics, Nemours Children\u2019s Health Delaware, Wilmington, DE 19803, USA"},{"name":"Center for Pediatric Research, Nemours Children\u2019s Health Delaware, Wilmington, DE 19803, USA"},{"name":"Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA"},{"name":"Department of Pediatrics, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy","volume":"3","author":"Crawford","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","article-title":"Spinal muscular atrophy","volume":"33","author":"Kolb","year":"2015","journal-title":"Neurol. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1046\/j.1471-0528.2002.02083.x","article-title":"Prenatal diagnosis for risk of spinal muscular atrophy","volume":"109","author":"Soler","year":"2002","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jmg.15.6.409","article-title":"Incidence, prevalence and gene frequency studies of chronic childhood spinal muscular atrophy","volume":"15","author":"Pearn","year":"1978","journal-title":"J. Med. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ejhg.2011.134","article-title":"Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: Clinical laboratory analysis of > 72400 specimens","volume":"20","author":"Sugarman","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/GIM.0b013e3182017c05","article-title":"Large-scale population screening for spinal muscular atrophy: Clinical implications","volume":"13","author":"Bardugo","year":"2011","journal-title":"Genet. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Su, Y.N., Hung, C.C., Lin, S.Y., Chen, F.Y., Chern, J.P.S., Tsai, C., Chang, T.S., Yang, C.C., Li, H., and Ho, H.N. (2011). Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005\u20132009: A prospective population-based cohort study. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017067"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/gtmb.2011.0149","article-title":"Spinal muscular atrophy carrier frequency and estimated prevalence of the disease in Moroccan newborns","volume":"16","author":"Lyahyai","year":"2012","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ana.24114","article-title":"Genetics of low spinal muscular atrophy carrier frequency in sub-Saharan Africa","volume":"75","author":"Hendrickson","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/01.wnl.0000172860.41953.12","article-title":"Evidence of reduced frequency of spinal muscular atrophy type I in the Cuban population","volume":"65","author":"Montejo","year":"2005","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.nmd.2007.05.005","article-title":"The molecular basis of spinal muscular atrophy (SMA) in South African black patients","volume":"17","author":"Labrum","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jmg.2009.066969","article-title":"Differences in SMN1 allele frequencies among ethnic groups within North America","volume":"46","author":"Hendrickson","year":"2009","journal-title":"J. Med. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: Relation to age, SMN2 copy number and function","volume":"57","author":"Swoboda","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA Consortium meeting","volume":"2","author":"Munsat","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0883073807305673","article-title":"Spinal muscular atrophy: Clinical classification and disease heterogeneity","volume":"22","author":"Russman","year":"2007","journal-title":"J. Child Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/joa.12083","article-title":"Spinal muscular atrophy: A motor neuron disorder or a multi-organ disease?","volume":"224","author":"Shababi","year":"2014","journal-title":"J. Anat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","article-title":"Spinal muscular atrophy: Going beyond the motor neuron","volume":"19","author":"Hamilton","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/labinvest.3700163","article-title":"Reduced expression of nicotinic AChRs in myotubes from spinal muscular atrophy I patients","volume":"84","author":"Arnold","year":"2004","journal-title":"Lab. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/NEN.0b013e3181a10ea1","article-title":"The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation","volume":"68","author":"Also","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1212\/01.WNL.0000052788.39340.45","article-title":"Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy","volume":"60","author":"Goebel","year":"2003","journal-title":"Neurology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.braindev.2012.03.009","article-title":"Peripheral nerve abnormalities in pediatric patients with spinal muscular atrophy","volume":"35","author":"Yonekawa","year":"2013","journal-title":"Brain Dev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00685353","article-title":"A neuropathological study of Werdnig-Hoffmann disease with special reference to the thalamus and posterior roots","volume":"60","author":"Shishikura","year":"1983","journal-title":"Acta Neuropathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0387-7604(03)00075-5","article-title":"Thalamic lesions in a long-surviving child with spinal muscular atrophy type I: MRI and EEG findings","volume":"26","author":"Ito","year":"2003","journal-title":"Brain Dev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/mus.21654","article-title":"Digital necroses and vascular thrombosis in severe spinal muscular atrophy","volume":"42","author":"Vogelgesang","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref_25","first-page":"175","article-title":"Cardiac involvement in patients with spinal muscular atrophies","volume":"30","author":"Palladino","year":"2011","journal-title":"Acta Myol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jpeds.2009.01.071","article-title":"Vascular perfusion abnormalities in infants with spinal muscular atrophy","volume":"155","author":"Araujo","year":"2009","journal-title":"J. Pediatr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.23582","article-title":"Glucose metabolism and pancreatic defects in spinal muscular atrophy","volume":"72","author":"Bowerman","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ana.410200615","article-title":"Dicarboxylic aciduria in an infant with spinal muscular atrophy","volume":"20","author":"Kelley","year":"1986","journal-title":"Ann. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0887-8994(94)00100-G","article-title":"Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: Primary or secondary defect(s)?","volume":"12","author":"Tein","year":"1995","journal-title":"Pediatr. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/1531-8249(199903)45:3<337::AID-ANA9>3.0.CO;2-U","article-title":"Abnormal fatty acid metabolism in childhood spinal muscular atrophy","volume":"45","author":"Crawford","year":"1999","journal-title":"Ann. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"K\u00f6lbel, H., Hauffa, B.P., Wudy, S.A., Bouikidis, A., Della Marina, A., and Schara, U. (2017). Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175611"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archpedi.1949.02030050237007","article-title":"Hereditary factors in infantile progressive muscular atrophy; study of 112 cases in 70 families","volume":"78","author":"Brandt","year":"1949","journal-title":"Am. J. Dis. Child."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0960-8966(96)00368-9","article-title":"Advances in SMA research: Review of gene deletions","volume":"6","author":"Morrison","year":"1996","journal-title":"Neuromuscul. Disord."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nature02919","article-title":"The DNA sequence and comparative analysis of human chromosome 5","volume":"431","author":"Schmutz","year":"2004","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1101\/gr.490303","article-title":"Segmental duplications in euchromatic regions of human chromosome 5: A source of evolutionary instability and transcriptional innovation","volume":"13","author":"Courseaux","year":"2003","journal-title":"Genome Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s004390100473","article-title":"SMN gene duplication and emergence of the SMN2 gene occured in distinct hominids: SMN2 is unique to Homo sapiens","volume":"108","author":"Rochette","year":"2001","journal-title":"Hum. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0092-8674(95)90461-1","article-title":"The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy","volume":"80","author":"Roy","year":"1995","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/hmg\/6.2.229","article-title":"A multicopy transcription-repair gene, BTF2p44, maps to the SMA region and demonstrates SMA associated deletions","volume":"6","author":"Carter","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_40","first-page":"72","article-title":"The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease","volume":"60","author":"Seroz","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/1753","article-title":"Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics","volume":"20","author":"Scharf","year":"1998","journal-title":"Nat. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ddmod.2004.07.001","article-title":"Perspectives on models of spinal muscular atrophy for drug discovery","volume":"1","author":"Butchbach","year":"2004","journal-title":"Drug Discov. Today Dis. Models"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmolb.2016.00007","article-title":"Copy number variations in the Survival Motor Neuron genes: Implications for spinal muscular atrophy and other neurodegenerative diseases","volume":"3","author":"Butchbach","year":"2016","journal-title":"Front. Mol. Biosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jmg.33.2.93","article-title":"Gene deletions in spinal muscular atrophy","volume":"33","author":"Rodrigues","year":"1996","journal-title":"J. Med. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jmg.33.4.281","article-title":"Large scale deletions of the 5q13 region are specific to Werdnig-Hoffmann disease","volume":"33","author":"Burlet","year":"1996","journal-title":"J. Med. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/hmg\/4.8.1273","article-title":"Allelic association and deletions in autosomal recessive proximal spinal muscular atrophy: Association of marker genotype with disease severity and candidate cDNAs","volume":"4","author":"Wirth","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/hmg\/5.2.257","article-title":"Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of c BCD541 and SMA phenotype","volume":"5","author":"Velasco","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: Why do low levels of survival motor neuron protein make motor neurons sick?","volume":"10","author":"Burghes","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","article-title":"The survival motor neuron protein in spinal muscular atrophy","volume":"6","author":"Coovert","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy","volume":"16","author":"Lefebvre","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Kolb, S.J., Gubitz, A.K., Olszewski, R.F., Ottinger, E., Sumner, C.J., Fischbeck, K.H., and Dreyfuss, G. (2006). A novel cell immunoassay to measure survival of motor neurons protein in blood cells. BMC Neurol., 6.","DOI":"10.1186\/1471-2377-6-6"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1212\/01.wnl.0000252934.70676.ab","article-title":"Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA","volume":"68","author":"Simard","year":"2007","journal-title":"Neurology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1212\/01.wnl.0000201929.56928.13","article-title":"SMN mRNA and protein levels in peripheral blood. Biomarkers for SMA clinical trials","volume":"66","author":"Sumner","year":"2006","journal-title":"Neurology"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Crawford, T.O., Paushkin, S., Kobayashi, D.T., Forrest, S.J., Joyce, C.L., Finkel, R.S., Kaufmann, P., Swoboda, K.J., Tiziano, F., and Lomastro, R. (2012). Evaluation of SMN protein, transcript and copy number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033572"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/sj.ejhg.5201885","article-title":"A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy","volume":"15","author":"Vezain","year":"2007","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ejhg.2009.116","article-title":"SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR","volume":"18","author":"Tiziano","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.embor.7400941","article-title":"Chaperoning ribonucleoprotein biogenesis in health and disease","volume":"8","author":"Pellizzoni","year":"2007","journal-title":"EMBO Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbagrm.2016.12.008","article-title":"Diverse role of survival motor neuron protein","volume":"1860","author":"Singh","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","article-title":"A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2","volume":"8","author":"Monani","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/hmg\/9.2.259","article-title":"An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN","volume":"9","author":"Lorson","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gad.1884910","article-title":"A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity","volume":"24","author":"Cho","year":"2010","journal-title":"Genes Dev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/MCB.01262-08","article-title":"Regulation of SMN protein stability","volume":"29","author":"Burnett","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMN\u03947, the major product of the centromeric survival motor neuron gene (SMN2), extends survival in mice with spinal muscular atrophy and associates with full-length SMN","volume":"14","author":"Le","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/515465","article-title":"Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number","volume":"60","author":"McAndrew","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajmg.a.30251","article-title":"Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2","volume":"130A","author":"Prior","year":"2005","journal-title":"Am. J. Med. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","article-title":"Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number","volume":"119","author":"Wirth","year":"2006","journal-title":"Hum. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mus.21350","article-title":"An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy","volume":"40","author":"Elsheikh","year":"2009","journal-title":"Muscle Nerve"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.nmd.2007.02.006","article-title":"The Hammersmith functional score correlates with the SMN2 copy number: A multicentric study","volume":"17","author":"Tiziano","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mgg3.141","article-title":"SMN1 and SMN2 copy numbers in cell lines derived from patients with spinal muscular atrophy as measured by array digital PCR","volume":"3","author":"Stabley","year":"2015","journal-title":"Mol. Genet. Genomic Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00125817-200201000-00004","article-title":"Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2","volume":"4","author":"Mailman","year":"2002","journal-title":"Genet. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/0883073814553271","article-title":"Association of copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein gene with the natural history in a Chinese spinal muscular atrophy cohort","volume":"30","author":"Qu","year":"2014","journal-title":"J. Child Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejpn.2011.07.007","article-title":"Correlation of SMN2, NAIP, p44, H4F5 and Occludin genes copy number with spinal muscular atrophy phenotype in Tunisian patients","volume":"16","author":"Amara","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/jhg.2015.104","article-title":"Joint effect of the SMN2 and SERF1A genes on childhood-onset types of spinal muscular atrophy in Serbian patients","volume":"60","author":"Brkusanin","year":"2015","journal-title":"J. Hum. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(95)90732-7","article-title":"PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy","volume":"345","author":"Grootscholten","year":"1995","journal-title":"Lancet"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Schwarzer","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/humu.10221","article-title":"Determination of SMN1 and SMN2 copy number using TaqMan technology","volume":"22","author":"Anhuf","year":"2003","journal-title":"Hum. Mutat."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10048-007-0093-1","article-title":"Robust quantification of the SMN gene copy number by real-time TaqMan PCR","volume":"8","author":"Robinson","year":"2007","journal-title":"Neurogenetics"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.ejhg.5200210","article-title":"Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy","volume":"6","author":"Taylor","year":"1998","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_80","first-page":"253","article-title":"Genotype determination at the survival motor neuron locus in a normal population and SMA carriers using competitive PCR and primer extension","volume":"16","author":"Ginet","year":"2004","journal-title":"Hum. Mutat."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/humu.20160","article-title":"Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: A highly efficient and reliable carrier-screening test","volume":"25","author":"Su","year":"2005","journal-title":"Hum. Mutat."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10048-006-0051-3","article-title":"Spinal muscular atrophy genotyping by gene dosage using multiple ligation-dependent probe amplification","volume":"7","author":"Scarciolla","year":"2006","journal-title":"Neurogenetics"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.nmd.2006.08.011","article-title":"Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy","volume":"16","author":"Arkblad","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/GIM.0b013e31803d35bc","article-title":"Copy number analysis of survival motor neuron genes by multiplex ligation-dependent probe amplification","volume":"9","author":"Huang","year":"2007","journal-title":"Genet. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/gtmb.2010.0253","article-title":"Accuracy of marker analysis, quantitative real-time polymerase chain reaction and multiple ligation-dependent probe amplification to determine SMN2 copy number in patients with spinal muscular atrophy","volume":"15","author":"Bernal","year":"2011","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Fang, P., Li, L., Zhou, W.J., Wu, W.Q., Zhong, Z.Y., Yan, T.Z., Xie, J.S., Huang, J., Lin, L., and Zhao, Y. (2015). Molecular characterization and copy number of SMN1, SMN2 and NAIP in Chinese patients with spinal muscular atrophy and unrelated healthy controls. BMC Musculoskelet. Disord., 16.","DOI":"10.1186\/s12891-015-0457-x"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/mgg3.10","article-title":"A homozygous double mutation in SMN1: A complicated genetic diagnosis of SMA","volume":"1","author":"Kirwin","year":"2013","journal-title":"Mol. Genet. Genomic Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1373\/clinchem.2012.183038","article-title":"Newborn screening for spinal muscular atrophy by calibrated short-amplicon melt profiling","volume":"58","author":"Dobrowolski","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00216-010-3761-1","article-title":"Universal fluorescent multiplex PCR and capillary electrophoresis for evaluation of gene conversion between SMN1 and SMN2 in spinal muscular atrophy","volume":"397","author":"Wang","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1002\/elps.201000124","article-title":"Multi-exon genotyping of SMN gene in spinal muscular atrophy by universal fluorescent PCR and capillary electrophoresis","volume":"31","author":"Wang","year":"2010","journal-title":"Electrophoresis"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.aca.2014.05.008","article-title":"Universal fluorescent tri-probe ligation equipped with capillary electrophoresis for targeting SMN1 and SMN2 genes in diagnosis of spinal muscular atrophy","volume":"833","author":"Wang","year":"2014","journal-title":"Anal. Chim. Acta"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e18809","DOI":"10.1097\/MD.0000000000018809","article-title":"The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy: Observational study","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10048-020-00630-5","article-title":"Detection of SMN1 and SMN2 gene conversion events and partial SMN1 deletions using array digital PCR","volume":"22","author":"Stabley","year":"2021","journal-title":"Neurogenetics"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA type and SMN2 copy number revisited: An analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases","volume":"28","author":"Calucho","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JND-200475","article-title":"Infants diagnosed with spinal muscular atrophy and 4 SMN2 copies through newborn screening\u2014Opportunity or burden?","volume":"7","author":"Vill","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e530","DOI":"10.1212\/NXG.0000000000000530","article-title":"Practical guidelines to manage discordant situations of SMN2 copy number in patients with spinal muscular atrophy","volume":"6","author":"Bernal","year":"2020","journal-title":"Neurol. Genet."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1101\/gr.7.4.339","article-title":"Cloning, characterization and copy number of the murine survival motor neuron gene: Homolog of the spinal muscular atrophy-determining gene","volume":"7","author":"DiDonato","year":"1997","journal-title":"Genome Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/geno.1996.4551","article-title":"cDNA isolation, expression and chromosomal localization of the mouse survival motor neuron gene (Smn)","volume":"40","author":"Viollet","year":"1997","journal-title":"Genomics"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","article-title":"Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos","volume":"94","author":"Schrank","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/hmg\/11.12.1439","article-title":"Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model","volume":"11","author":"Nicole","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1083\/jcb.200210117","article-title":"Intact satellite cells lead to remarkable protection against Smn gene defect in differentiation skeletal muscle","volume":"161","author":"Nicole","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0002-9440(10)63428-1","article-title":"Deletion of murine Smn exon 7 directed to liver leads to severe defect of liver development associated with iron overload","volume":"165","author":"Vitte","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-\/- mice and results in a mouse with spinal muscular atrophy","volume":"9","author":"Monani","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Chang","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nbd.2010.01.006","article-title":"Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy","volume":"38","author":"Michaud","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1093\/hmg\/ddp310","article-title":"Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects","volume":"18","author":"Boon","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1326-6-24","article-title":"Generation and characterization of a genetic zebrafish model of SMA carrying the human SMN2 gene","volume":"6","author":"Burghes","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"fcaa075","DOI":"10.1093\/braincomms\/fcaa075","article-title":"Intragenic and structural variation in the SMN locus and clinical variability in spinal muscular atrophy","volume":"2","author":"Wadman","year":"2020","journal-title":"Brain Commun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/GIM.0b013e318220d523","article-title":"Technical standards and guidelines for spinal muscular atrophy testing","volume":"13","author":"Prior","year":"2011","journal-title":"Genet. Med."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Vijzelaar, R., Senetsalaar, R., Clausen, M., Mason, A.G., Rinsma, M., Zegers, M., Molleman, N., Boschloo, R., Yilmaz, R., and Kuilboer, R. (2019). The frequency of SMN gene variants lacking exon 7 and 8 is highly population dependent. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220211"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1039\/c1lc20126c","article-title":"Multiplex digital PCR: Breaking the one target per color barrier of quantitative PCR","volume":"11","author":"Zhong","year":"2011","journal-title":"Lab Chip"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.nmd.2017.02.002","article-title":"Establishing a reference dataset for the authentication of spinal muscular atrophy cell lines using STR profiling and digital PCR","volume":"27","author":"Stabley","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1373\/clinchem.2018.293712","article-title":"Multiplex droplet digital PCR method applicable to newborn screening, carrier status and assessment of spinal muscular atrophy","volume":"64","author":"Gavrilov","year":"2018","journal-title":"Clin. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cca.2020.09.024","article-title":"Analytical validation of the droplet digital PCR assay for the diagnosis of spinal muscular atrophy","volume":"510","author":"Park","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"19892","DOI":"10.1038\/s41598-020-76893-7","article-title":"Development and validation of a 4-color multiplexing spinal muscular atrophy (SMA) genotyping assay on a novel integrated digital PCR instrument","volume":"10","author":"Jiang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Larson, J.L., Silver, A.J., Chan, D., Borroto, C., Spurrier, B., and Silver, L.M. (2015). Validation of a high resolution NGS method for detecting spinal muscular atrophy carriers among phase 3 participants in the 1000 Genomes Project. BMC Med. Genet., 16.","DOI":"10.1186\/s12881-015-0246-2"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/gim.2016.215","article-title":"The next generation of population-based spinal muscular atrophy carrier screening: Comprehensive pan-ethnic SMN1 copy-number and sequence variant analysis by massively parallel sequencing","volume":"19","author":"Feng","year":"2017","journal-title":"Genet. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/humu.24120","article-title":"SMN1 copy-number and sequence variant analysis from next-generation sequencing data","volume":"41","author":"Loucera","year":"2020","journal-title":"Hum. Mutat."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1089\/gtmb.2019.0282","article-title":"Incorporating spinal muscular atrophy analysis by next-generation sequencing into a comprehensive multigene panel for neuromuscular diseases","volume":"24","author":"Tan","year":"2020","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41436-020-0754-0","article-title":"Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data","volume":"22","author":"Chen","year":"2020","journal-title":"Genet. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1086\/513913","article-title":"When is a deletion not a deletion? When it is converted","volume":"61","author":"Burghes","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/513886","article-title":"Genomic variation and gene conversion in spinal muscular atrophy: Implications for disease process and clinical phenotype","volume":"61","author":"Campbell","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ana.410410214","article-title":"Deletion and conversion in spinal muscular atrophy: Is there a relationship to severity?","volume":"41","author":"DiDonato","year":"1997","journal-title":"Ann. Neurol."},{"key":"ref_124","first-page":"1057","article-title":"Hybrid survival motor neuron genes in patients with autosomal recessive spinal muscular atrophy: New insights into molecular mechanisms responsible for the disease","volume":"59","author":"Hahnen","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"ref_125","first-page":"834","article-title":"Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus at chromosome 5","volume":"59","author":"Grootscholten","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ana.410400509","article-title":"Clinical and molecular genetic features of congenital spinal muscular atrophy","volume":"40","author":"Devriendt","year":"1996","journal-title":"Ann. Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jmoldx.2016.05.004","article-title":"Mutation spectrum of the survival of motor neuron 1 and functional analysis of variants in Chinese spinal muscular atrophy","volume":"18","author":"Qu","year":"2016","journal-title":"J. Mol. Diagn."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/s41431-018-0193-4","article-title":"Utility of two SMN1 variants to improve spinal muscular atrophy carrier diagnosis and genetic counselling","volume":"26","author":"Bernal","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/jhg.2015.16","article-title":"A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencing","volume":"60","author":"Kubo","year":"2015","journal-title":"J. Hum. Genet."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jns.2011.06.002","article-title":"Identification of bidirectional gene conversion between SMN1 and SMN2 by simultaneous analysis of SMN dosage and hybrid genes in a Chinese population","volume":"308","author":"Chen","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.ejhg.5200957","article-title":"Inverse correlation between SMN1 and SMN2 copy numbers: Evidence for gene conversion from SMN2 to SMN1","volume":"11","author":"Ogino","year":"2003","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1034\/j.1600-0404.2003.00181.x","article-title":"Gene conversion events in adult-onset spinal muscular atrophy","volume":"109","author":"Mazzei","year":"2004","journal-title":"Acta Neurol. Scand."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s004390000452","article-title":"Characterization of SMN hybrid genes in Spanish SMA patients: De novo, homozygous and compound heterozygous cases","volume":"108","author":"Bussaglia","year":"2001","journal-title":"Hum. Genet."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.tins.2020.11.009","article-title":"Spinal muscular atrophy: In the challenge lies a solution","volume":"44","author":"Wirth","year":"2021","journal-title":"Trends Neurosci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00439-019-01983-0","article-title":"Complete sequencing of the SMN2 gene in SMA patients detect SMN gene deletion junctions and variants in SMN that modify the SMA phenotype","volume":"138","author":"Ruhno","year":"2019","journal-title":"Hum. Genet."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/humu.24200","article-title":"Beyond copy number: A new, rapid and versatile methods for sequencing the entire SMN2 gene in SMA patients","volume":"42","author":"Paramonov","year":"2021","journal-title":"Hum. Mutat."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/ddx166","article-title":"A-44G transition in SMN2 intron 6 protects patients with spinal muscular atrophy","volume":"26","author":"Wu","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1073\/pnas.0700343104","article-title":"An intronic element contributes to splicing repression in spinal muscular atrophy","volume":"104","author":"Kashima","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","article-title":"A positive modifier of spinal muscular atrophy in the SMN2 gene","volume":"85","author":"Prior","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"E1110","DOI":"10.1002\/humu.21173","article-title":"A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy","volume":"31","author":"Vezain","year":"2010","journal-title":"Hum. Mutat."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jmg.2010.079004","article-title":"The c.859G>C variant in the SMN2 gene is associated with types II and III SMA and originates from a common ancestor","volume":"47","author":"Bernal","year":"2010","journal-title":"J. Med. Genet."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/ana.410440522","article-title":"Spinal muscular atrophy due to an isolated deletion of exon 8 of the telomeric survival motor neuron gene","volume":"44","author":"Gambardella","year":"1998","journal-title":"Ann. Neurol."},{"key":"ref_143","first-page":"1735","article-title":"Homozygous SMN1 exons 1-6 deletion: Pitfalls in genetic counseling and general recommendations for spinal muscular atrophy molecular diagnosis","volume":"158","author":"Drunat","year":"2012","journal-title":"Am. J. Med. Genet."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1086\/302369","article-title":"Quantitative analysis of survival motor neuron copies: Identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation and implications for genetic counseling","volume":"64","author":"Wirth","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e1238","DOI":"10.1002\/mgg3.1238","article-title":"Spinal muscular atrophy caused by a novel Alu-mediated deletion of exons 2a-5 in SMN1 undetectable with routine genetic testing","volume":"8","author":"Majer","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/gb-2011-12-12-236","article-title":"Alu elements: Know the SINEs","volume":"12","author":"Deininger","year":"2011","journal-title":"Genome Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3389\/fmicb.2017.02252","article-title":"A multilayered control of the human Survival Motor Neuron gene expression by Alu elements","volume":"8","author":"Ottesen","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1086\/504600","article-title":"Human genomic deletions mediated by recombination between Alu elements","volume":"79","author":"Sen","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJMoa2009965","article-title":"Risdiplam in type 1 spinal muscular atrophy","volume":"384","author":"Baranello","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JND-180304","article-title":"Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screening","volume":"5","author":"Glascock","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JND-190468","article-title":"Revised recommendations for the treatment of infants diagnosed with spinal muscular atrophy via newborn screening who have 4 copies of SMN2","volume":"7","author":"Glascock","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1089\/gtmb.2014.0002","article-title":"Subtle mutation detection of SMN1 gene in Chinese spinal muscular atrophy patients: Implications of molecular diagnostic procedure for SMN1 gene mutations","volume":"18","author":"Bai","year":"2014","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/humu.20111","article-title":"Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy","volume":"25","author":"Sun","year":"2005","journal-title":"Hum. Mutat."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.braindev.2021.03.006","article-title":"Phenotypes of SMA patients retaining SMN1 with intragenic mutation","volume":"43","author":"Wijaya","year":"2021","journal-title":"Brain Dev."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/0883073807305668","article-title":"Spinal muscular atrophy diagnostics","volume":"22","author":"Prior","year":"2007","journal-title":"J. Child Neurol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.ejhg.5200599","article-title":"Premature termination mutations in exon 3 of the SMN1 gene are associated with exon skipping and a relatively mild SMA phenotype","volume":"9","author":"Sossi","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1212\/NXG.0000000000000505","article-title":"Intragenic variants in the SMN1 gene determine the clinical phenotype in 5q spinal muscular atrophy","volume":"6","author":"Polido","year":"2020","journal-title":"Neurol. Genet."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00439-007-0455-7","article-title":"Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy","volume":"123","author":"Brichta","year":"2008","journal-title":"Hum. Genet."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00439-008-0598-1","article-title":"Mutation update of spinal muscular atrophy in Spain: Molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene","volume":"125","author":"Bernal","year":"2009","journal-title":"Hum. Genet."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(01)00574-3","article-title":"Molecular analysis of SMN, NAIP and P44 genes of SMA patients and their families","volume":"190","author":"Tsai","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nmd.2019.11.010","article-title":"Identification of novel SMN1 subtle mutations using an allele-specific RT-PCR","volume":"30","author":"Xu","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.gene.2012.12.109","article-title":"Molecular analysis of SMN1, SMN2, NAIP, GTF2H2 and H4F5 genes in 157 Chinese patients with spinal muscular atrophy","volume":"518","author":"He","year":"2013","journal-title":"Gene"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/0883073814521297","article-title":"Deletion of intragenic SMN1 mutations in spinal muscular atrophy patients with a single copy of SMN1","volume":"30","author":"Ganji","year":"2015","journal-title":"J. Child Neurol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jmoldx.2010.11.009","article-title":"Establishment of a molecular diagnostic system for spinal muscular atrophy. Experience from a clinical laboratory in China","volume":"13","author":"Zeng","year":"2011","journal-title":"J. Mol. Diagn."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Qu, Y., Du, J., Li, E., Bai, J., Jin, Y., Hong, W., Wang, H., and Song, F. (2012). Subtle mutations in the SMN1 gene in Chinese patients with SMA: p.Arg288Met mutation causing SMN1 transcript exclusion of exon7. BMC Med. Genet., 13.","DOI":"10.1186\/1471-2350-13-86"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s004390100497","article-title":"Characterisation of novel point mutations in the survival motor neuron gene SMN, in three patients with SMA","volume":"108","author":"Skordis","year":"2001","journal-title":"Hum. Genet."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.nmd.2007.03.003","article-title":"Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy","volume":"17","author":"Kalina","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.nmd.2014.04.003","article-title":"Novel point mutations in survival motor neuron 1 gene expand the spectrum of phenotypes observed in spinal muscular atrophy patients","volume":"24","author":"Jedrzejowska","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/humu.20092","article-title":"Molecular analysis of SMA patients without homozygous SMN1 deletions using a new strategy for identification of SMN1 subtle mutations","volume":"24","author":"Clermont","year":"2004","journal-title":"Hum. Mutat."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng1195-335","article-title":"A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients","volume":"11","author":"Bussaglia","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1093\/hmg\/5.12.1971","article-title":"Frameshift mutation in the survival motor neuron gene in a severe case of SMA type I","volume":"5","author":"Brahe","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/gtmb.2010.0164","article-title":"New approaches in molecular diagnosis and population carrier screening for spinal muscular atrophy","volume":"15","author":"Oliveira","year":"2011","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1086\/302160","article-title":"Intragenic telSMN mutations: Frequency, distribution, evidence of a founder effect and modification of the spinal muscular atrophy phenotype by cenSMN copy number","volume":"63","author":"Parsons","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jmg.35.8.674","article-title":"Diagnosis of spinal muscular atrophy in an SMN non-deletion patient with quantitative PCR screen and mutation analysis","volume":"35","author":"Parsons","year":"1998","journal-title":"J. Med. Genet."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Sharifi, Z., Taheri, M., Fallah, M.S., Abiri, M., Golnabi, F., Begherian, H., Zeinali, R., Farahzadi, H., Alborji, M., and Tehrani, P.G. (2021). Comprehensive mutation analysis and report of 12 novel mutations in a cohort of patients with spinal muscular atrophy in Iran. J. Mol. Neurosci., in press.","DOI":"10.1007\/s12031-020-01789-0"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00439-002-0681-y","article-title":"Genetic study of SMA patients without homozygous SMN1 deletions: Identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations","volume":"110","author":"Valero","year":"2002","journal-title":"Hum. Genet."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1093\/hmg\/5.11.1727","article-title":"An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: Further evidence for SMN as the primary SMA-determining gene","volume":"5","author":"Parsons","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.braindev.2017.03.002","article-title":"SMA mutations in SMN Tudor and C-terminal domains destabilize the protein","volume":"39","author":"Takarada","year":"2017","journal-title":"Brain Dev."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.braindev.2013.11.009","article-title":"Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients","volume":"36","author":"Yamamoto","year":"2014","journal-title":"Brain Dev."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s00415-006-0410-x","article-title":"A novel mutation at the N-terminal of SMN Tudor domain inhibits its interaction with target proteins","volume":"254","author":"Kotani","year":"2007","journal-title":"J. Neurol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"104006","DOI":"10.1016\/j.ejmg.2020.104006","article-title":"Identification of two novel SMN1 point mutations associated with a very severe SMA-I phenotype","volume":"63","author":"Zhao","year":"2020","journal-title":"Eur. J. Med. Genet."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1212\/01.WNL.0000132634.48815.13","article-title":"Detection of novel mutations in the SMN Tudor domain in type I SMA patients","volume":"63","author":"Baiget","year":"2004","journal-title":"Neurology"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1212\/WNL.0b013e318247ca69","article-title":"Genotype-phenotype relationship in 2 SMA III patients with novel mutations in the Tudor domain","volume":"78","author":"Fraidakis","year":"2012","journal-title":"Neurology"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)","volume":"15","author":"Wirth","year":"2000","journal-title":"Hum. Mutat."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/jnnp-2016-314292","article-title":"Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0-4","volume":"88","author":"Wadman","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s100480050021","article-title":"Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7","volume":"1","author":"Rochette","year":"1997","journal-title":"Neurogenetics"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/hmg\/6.5.821","article-title":"Missense mutations in exon 6 of the survival motor neuron gene in patients with spinal muscular atrophy (SMA)","volume":"6","author":"Hahnen","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"Sumner","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.braindev.2017.06.002","article-title":"Spinal muscular atrophy carriers with two SMN1 copies","volume":"39","author":"Awano","year":"2017","journal-title":"Brain Dev."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s100480050040","article-title":"Identification of a novel missense mutation of the SMNT gene in two siblings with spinal muscular atrophy","volume":"1","author":"Wang","year":"1998","journal-title":"Neurogenetics"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/6.3.497","article-title":"Missense mutation clustering in the survival motor neuron gene: A role for conserved tyrosine and glycine rich region of the protein in RNA metabolism?","volume":"6","author":"Talbot","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/gtmb.2008.0158","article-title":"False homozygous deletions of SMN1 exon 7 using Dra I PCR-RFLP caused by a novel mutation in spinal muscular atrophy","volume":"13","author":"Kang","year":"2009","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_196","first-page":"385","article-title":"Compound heterozygous mutation in two unrelated cases of Chinese spinal muscular atrophy patients","volume":"124","author":"Qu","year":"2011","journal-title":"Chin. Med. J."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ejhg.2010.54","article-title":"Molecular characterization of SMN copy number derived from carrier screening and from core families with SMA in a Chinese population","volume":"18","author":"Zhu","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.nmd.2007.10.003","article-title":"A new splice site mutation in the SMN1 gene causes discrepant results in SMN1 deletion screening approaches","volume":"18","author":"Eggermann","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200208079","article-title":"A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy","volume":"160","author":"Monani","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/hmg\/ddp157","article-title":"A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice","volume":"18","author":"Workman","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1093\/hmg\/ddy251","article-title":"Mild SMN missense alleles are only functional in the presence of SMN2 in mammals","volume":"27","author":"Iyer","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1523\/JNEUROSCI.1637-06.2006","article-title":"Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis","volume":"26","author":"Carrel","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1093\/hmg\/ddaa235","article-title":"Intragenic complementation of amino and carboxy terminal SMN missense mutations can rescue Smn null mice","volume":"29","author":"McGovern","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s004390000446","article-title":"Hybrids monosomal for human chromosome 5 reveal the presence of a spinal muscular atrophy (SMA) carrier with two SMN1 copies on one chromosome","volume":"108","author":"Mailman","year":"2001","journal-title":"Hum. Genet."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/cge.12222","article-title":"Improving detection and genetic counseling in carriers of spinal muscular atrophy with two copies of the SMN1 gene","volume":"85","author":"Bernal","year":"2014","journal-title":"Clin. Genet."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/gim.2013.84","article-title":"An Ashkenazi Jewish SMN1 haplotype specific to duplication alleles improves pan-ethnic carrier screening for spinal muscular atrophy","volume":"16","author":"Luo","year":"2014","journal-title":"Genet. Med."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jmoldx.2020.10.011","article-title":"Characterization of reference materials for spinal muscular atrophy genetic testing: A Genetic Testing Reference Materials Coordination Program collaborative project","volume":"23","author":"Prior","year":"2021","journal-title":"J. Mol. Diagn."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s10072-020-04365-x","article-title":"SMN1 gene copy number analysis for spinal muscular atrophy (SMA) in a Turkish cohort by CODE-SEQ technology, an integrated solution for detection of SMN1 and SMN2 copy numbers and the \u201c2+0\u201d genotype","volume":"41","author":"Ceylan","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/labmed\/lmz088","article-title":"Enhanced carrier screening for spinal muscular atrophy: Detection of silent (SMN1:2+0) carriers utilizing a novel TaqMan genotyping method","volume":"51","author":"Azad","year":"2020","journal-title":"Lab. Med."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/jmg.33.12.1019","article-title":"Evidence for compound heterozygositiy causing mild and severe forms of autosomal recessive spinal muscular atrophy","volume":"33","author":"Talbot","year":"1996","journal-title":"J. Med. Genet."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1136\/jnnp.2003.018614","article-title":"Phenotypic variability in siblings with type III spinal muscular atrophy","volume":"75","author":"Muqit","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1651-2227.2008.01201.x","article-title":"A population-based study of genotypic and phenotypic variability in children with spinal muscular atrophy","volume":"98","author":"Arkblad","year":"2009","journal-title":"Acta Paediatr."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JND-190399","article-title":"Spinal muscular atrophy (SMA) subtype concordance in siblings: Findings from the Cure SMA cohort","volume":"7","author":"Jones","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00212028","article-title":"Linkage mapping of the spinal muscular atrophy gene","volume":"93","author":"Burghes","year":"1994","journal-title":"Hum. Genet."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/4.10.1927","article-title":"Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: Evidence of homozygous deletions of the SMN gene in unaffected individuals","volume":"4","author":"Hahnen","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"ref_216","first-page":"805","article-title":"Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy","volume":"57","author":"Cobben","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00415-005-0912-y","article-title":"SMN2 copy number predicts acute or chronic spinal muscular atrophy but does not account for intrafamilial variability in siblings","volume":"253","author":"Illa","year":"2006","journal-title":"J. Neurol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.gde.2013.03.003","article-title":"How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic applications","volume":"23","author":"Wirth","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1155085","article-title":"Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy","volume":"320","author":"Oprea","year":"2008","journal-title":"Science"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archneurol.2010.239","article-title":"Association of plastin 3 expression with disease severity in spinal muscular atrophy only in postpubertal females","volume":"67","author":"Stratigopoulos","year":"2010","journal-title":"Arch. Neurol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/jhg.2013.111","article-title":"Correlation of PLS3 expression with disease severity in children with spinal muscular atrophy","volume":"59","author":"Yanyan","year":"2014","journal-title":"J. Hum. Genet."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nmd.2011.03.009","article-title":"Plastin 3 expression in discordant spinal muscular atrophy (SMA) siblings","volume":"21","author":"Bernal","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ped.13052","article-title":"Transcript levels of plastin 3 and neuritin 1 modifer genes in spinal muscular atrophy siblings","volume":"59","author":"Yener","year":"2017","journal-title":"Pediatr. Int."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1212\/NXG.0000000000000386","article-title":"Analysis of FUS, PFN2, TDP-43 and PLS3 as potential disease severity modifiers in spinal muscular atrophy","volume":"6","author":"Wadman","year":"2020","journal-title":"Neurol. Genet."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ajhg.2016.07.014","article-title":"The power of human protective modifiers: PLS3 and CORO1C unravel impaired endocytosis in spinal muscular atrophy and rescue SMA phenotype","volume":"99","author":"Hosseinibarkooie","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1093\/brain\/awy167","article-title":"CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis","volume":"141","author":"Janzen","year":"2018","journal-title":"Brain"},{"key":"ref_227","first-page":"4494","article-title":"Effect of genetic background on the phenotype of the Smn2B\/- mouse model of spinal muscular atrophy","volume":"25","author":"Eshraghi","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/hmg\/dds540","article-title":"Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality","volume":"22","author":"Ackermann","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"McGovern, V.L., Massoni-Laporte, A., Wang, X., Le, T.T., Le, H.T., Beattie, C.E., Rich, M.M., and Burghes, A.H.M. (2015). Plastin 3 expression does not modify spinal muscular atrophy severity in the \u03947 SMA mouse. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132364"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"e89970","DOI":"10.1172\/jci.insight.89970","article-title":"Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy","volume":"2","author":"Kaifer","year":"2017","journal-title":"JCI Insight"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.omtm.2018.01.007","article-title":"Plastin 3 promotes motor axonal growth and extends survival in a mouse model of spinal muscular atrophy","volume":"9","author":"Alrafiah","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ajhg.2017.01.005","article-title":"Neurocalcin Delta suppression protects against spinal muscular atrophy in humans and acress species by restoring impaired endocytosis","volume":"100","author":"Riessland","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Jiang, J., Huang, J., Gu, J., Cai, X., Zhao, H., and Lu, H. (2019). Genomic analysis of a spinal muscular atrophy (SMA) discordant family identifies a novel mutation in TLL2, an activator of growth differentiation factor 8 (myostatin): A case report. BMC Med. Genet., 20.","DOI":"10.1186\/s12881-019-0935-3"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/hmg\/ddy382","article-title":"Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy","volume":"28","author":"Long","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"10337","DOI":"10.1073\/pnas.1104928108","article-title":"Interaction of survival of motor neuron (SMN) with HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits","volume":"108","author":"Akten","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/adt.2014.587","article-title":"Assays for the identification and prioritization of drug candidates for spinal muscular atrophy","volume":"12","author":"Cherry","year":"2014","journal-title":"Assay Drug Dev. Technol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.23995","article-title":"Spinal muscular atrophy: Development and implementation of potential therapeutics","volume":"74","author":"Arnold","year":"2013","journal-title":"Ann. Neurol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/15\/7896\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:34:10Z","timestamp":1760164450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/15\/7896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":237,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ijms22157896"],"URL":"https:\/\/doi.org\/10.3390\/ijms22157896","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]}}}